News and media

The Australian Government will invest $26 million in health and medical research to improve treatment and care for LGBTIQA+ people. Funding is from the Medical Research Future Fund (MRFF).

Researchers can apply for funding under the 2023 International Clinical Trial Collaborations grant opportunity. Funding is from the Medical Research Future Fund (MRFF).

Vaccination against influenza (flu) continues to be important this year. Vaccination is our best defence against flu viruses.

The Australian Government has responded to the Halton review into COVID-19 vaccine and treatment procurement.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

In 2018 Scott Griffiths developed a deadly rare blood cancer in his brain. He believed he was going to die. But a new precision medicine developed by his doctor Professor Maher Gandhi cured Scott. Maher is conducting a clinical trial to test if his new treatment works for other patients.

Over 90% of childhood brain cancer survivors develop life threatening and disabling health conditions after they finish cancer treatment. Engage is a consumer co-designed telehealth trial that helps these survivors manage their health and improve their quality of life.

We invite all research administration officers (RAOs) to join our next Medical Research Future Fund (MRFF) RAO Webinar at 2:00pm (AEDT) on 30 March 2023.

We invite you to join our next Medical Research Future Fund (MRFF) Webinar at 2:00pm (AEDT) on 15 March 2023.

Researchers can apply for funding under the 2023 Global Health grant opportunity from 27 March 2023. Funding is from the Medical Research Future Fund (MRFF).

Medical Research Future Fund (MRFF) grant opportunities to the value of $310.3 million are now available.

It takes time and money to turn a scientific discovery into a medical product ready for use. To help medical researchers along this road, in 2017 the MRFF began funding medical research commercialisation. The Big Picture asks what impact our funds are having.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine.

Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 boosters in 2023. These recommendations replace previous ATAGI COVID-19 vaccine booster advice.

A Pharmacist and Practice Manager from across Australia were sentenced last week after fraudulently claiming more than $470,000 in payments under the Medicare Benefits Scheme (MBS) and the Pharmaceutical Benefits Scheme (PBS).

From 6 February 2023 the human papillomavirus (HPV) vaccine schedule will become a single dose schedule. Catch-up under the National Immunisation Program (NIP) will also be extended to all Australians 25 years and under.

The Strengthening Medicare Taskforce Report is now available. It outlines a vision for Australia’s primary care system of the future.

Big data is giving us a whole picture of Australia’s ageing pathways for the first time. Professor Maria Inacio is working with this data from the Registry of Senior Australians. She aims to find the best aged care and health care services for older Australians.

A medical receptionist from south-eastern Queensland has been convicted after fraudulently claiming more than $253,000 in Medicare payments.

The National Dementia Action Plan is open for consultation. Find out about the plan and how to provide feedback.

We are seeking expressions of interest to fill 7 vacancies on the Australian Technical Advisory Group on Immunisation (ATAGI), commencing 1 July 2023. Consider applying if you are a clinical professional, researcher, service delivery expert or consumer expert.

In 2020, 5 Australian research organisations with expertise in infectious diseases and 2 industry partners formed a consortium. Their aim: to produce an Australian antiviral drug for COVID-19. This research is growing Australia’s ability to discover, test, and manufacture antiviral drugs.

From 21 December 2022, vaccination providers must report all Japanese encephalitis virus (JEV) vaccines administered to the Australian Immunisation Register (AIR).

Read the transcript of Therapeutic Goods Administration Adjunct Professor John Skerritt's interview with Hamish Macdonald on ABC Radio National on 9 January 2023.

If you are considering cosmetic surgery, it is important that you get trustworthy information first. Information and resources are now available to help you make the safer choice.